Proskauer has advised Dimension. Dimension, a venture capital firm focused on the intersection of biotechnology and artificial intelligence, has announced the closing of its latest fund,...
Dimension Closes $800 Million Fund to Expand Science and Compute Investments
Columbia Capital to Be Acquired by Digital Realty in $485 Million Deal
Proskauer has advised Columbia Capital. Columbia Capital has entered into an agreement to be acquired by Digital Realty, the world’s largest cloud- and carrier-neutral data center...
Thrive Capital Closes $10 Billion Thrive X Fund
Proskauer has advised Thrive Capital. Thrive Capital has announced the closing of its latest investment fund, Thrive X, which has secured more than $10 billion in...
CRV Reaches $750 Million Final Close for Oversubscribed Venture Fund
Proskauer has advised CRV on the closing of CRV XX, LP. CRV has announced the first and final closing of its latest venture fund, CRV XX,...
Atomico’s Closing of Atomico Growth VI
Proskauer advised Atomico on the transaction. Atomico, a European venture capital firm, announced the closing of fund Atomico Growth VI (“Growth VI”). Growth VI closed with...
Atomico’s Closing of Atomico Venture VI
Proskauer advised Atomico on the transaction. Atomico, a European venture capital firm, announced the closing of fund Atomico Venture VI (“Venture VI”). Venture VI, an early-stage...
Flagship Pioneering’s $3.6 Billion Fundraising
Proskauer represented Flagship Pioneering in the transaction. Flagship Pioneering (“Flagship”), a bioplatform innovation company, raised an additional $3.6 billion of capital to fund the creation and...
HighVista Strategies’ Acquisition of U.S. Private Market Business of Abrdn
Sidley represented HighVista Strategies, while Proskauer represented abrdn in the transaction. Global asset manager abrdn Inc. (“abrdn”) announced its definitive agreement to sell its U.S. private...
Flagship Pioneering’s $3.4 Billion Fund VII Closing
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...